Computer Study of Preventive Biostimulator Treatments to Reduce Facial Sagging Linked to Weight Loss from GLP-1 Drugs

Declarations. Conflict of interest: Dr Rao worked as a consultant and speaker for Allergan Aesthetics an AbbVie company (Irvine, CA); Dr Michon is a consultant, and speaker for Allergan Aesthetics an AbbVie Company), consultant for Galderma Canada and SkinCeuticals Canada, L’Oréal Paris; Dr Joseph is an investigator and advisory board member for Allergan Aesthetics, an AbbVie company (Irvine, CA); clinical investigator for Galderma (Lausanne, Switzerland), Merz (Raleigh, NC), Evolus (Newport Beach, CA), Revance (Newark, CA), and Croma (Leobendorf, Austria); speaker or consultant for Galderma, Merz, and Evolus; advisor for Revance and Croma; and shareholder for Evolus and Revance. Dr Joseph is the Chief Medical Officer for Amalfi-Bio. Dr Wu is a speaker and consultant for Allergan Aesthetics an AbbVie Company, Merz Pharmaceuticals GmbH; Dr Webb is the founder of AesthetiSIM. Dr Rahman, Dr Saklayen and Dr Ahmed have nothing to declare. Human Rights and Animal Participants: This article does not contain any studies with human participants or animals performed by any of the authors. Informed Consent: For this type of study, informed consent is not required. However, explicit consent was obtained to use photography for publication.